Surgical Science Sweden AB (OSTO:SUS) Total Noninterest Expense

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:SUS Surgical Science Sweden AB OSTO:SUS
86 GF Score
Price kr49.30
GF Value kr155.98
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Surgical Science Sweden AB Total Noninterest Expense?

Total Noninterest Expense only applies to banks.

OSTO:SUS
86GF Score
Surgical Science Sweden AB OSTO:SUS
Total Noninterest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Surgical Science Sweden AB (OSTO:SUS) Overvalued in 2026?

Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued. The current stock price of kr49.30 is trading 68.4% below its estimated GF Value™ of kr155.98. GuruFocus considers Surgical Science Sweden AB to be Significantly Undervalued.

Key valuation signals for OSTO:SUS:

  • Total Noninterest Expense:
  • GF Value™: kr155.98 vs. price of kr49.30 (68.4% below fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the OSTO:SUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Surgical Science Sweden AB Business Description

Other Exchanges SUSRF:USA4P41:Germany
Address Drakegatan 7A, Gothenburg, SWE, SE-412 50
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
86GF Score

Get the complete analysis for OSTO:SUS

Total Noninterest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr49.30
Price
kr155.98
GF Value